Non-cholestatic acute hepatitis following Candesartan administration.

Abstract

Arterial hypertension is nowadays a highly manageable disorder due to a variety of drugs available for its treatment. Since the late 1990's, angiotensin II receptor blockers have been widely prescribed, achieving appropriate control in patients' blood pressure. Few cases of serious adverse effects have been reported to date. Here we present a case of acute hepatocellular injury secondary to candesartan administration. Further studies should be performed in patients who present this effect in order to prevent more serious outcomes.

http://ift.tt/2waSvff